Premium
P1‐030: Chronic nicotine administration does not reduce beta‐amyloid levels in a transgenic mouse model for Alzheimer's disease
Author(s) -
Sabbagh Marwan N.,
Lue LihFen,
Reid Richard,
Walker Douglas
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.615
Subject(s) - nicotine , genetically modified mouse , neuroprotection , amyloid precursor protein , transgene , chemistry , pharmacology , amyloid beta , in vivo , neurotoxicity , hippocampus , amyloid (mycology) , toxicity , biochemistry , endocrinology , medicine , biology , alzheimer's disease , disease , peptide , gene , inorganic chemistry , microbiology and biotechnology